The global AI Imaging & Diagnostics market size is predicted to grow from US$ 7101 million in 2025 to US$ 27913 million in 2032; it is expected to grow at a CAGR of 21.6% from 2026 to 2032.

AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.

The market can be classified by data type (imaging-based, signal-based, multi-modal), by clinical function (detection, segmentation, classification, severity scoring, diagnostic recommendation), by medical specialty (radiology, cardiology, oncology, neurology, ophthalmology, primary care), by deployment model (on-premise, cloud SaaS, device-embedded, edge-based), and by regulatory/commercial type (standalone SaMD, bundled software, clinical decision support, screening-focused solutions). These dimensions reflect both technical complexity and commercial pathways.

Key costs arise from data acquisition and labeling, algorithm development, clinical trials, regulatory compliance, and continuous model updates. With software-centric economics, gross margins generally range from 65% to 80%. Transactions are dominated by subscription SaaS, per-study pricing, and multi-year enterprise licenses, often bundled with imaging systems or workflow platforms. Market trends include rapid regulatory approvals, consolidation through M&A, deeper OEM integration, expansion beyond radiology into multi-disciplinary diagnostics, and accelerating adoption driven by value-based care and clinician shortages.

LPI (LP Information) newest research report, the ?AI Imaging & Diagnostics Industry Forecast? looks at past sales and reviews total world AI Imaging & Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected AI Imaging & Diagnostics sales for 2026 through 2032. With AI Imaging & Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Imaging & Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global AI Imaging & Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Imaging & Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global AI Imaging & Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Imaging & Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Imaging & Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of AI Imaging & Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

    X-ray / CXR
    CT
    MRI
    Ultrasound
    Mammography / DBT
    Others
    Segmentation by Diagnostic Data Type:
    Medical Imaging?based
    Physiological Signals?based
    Ophthalmic Imaging?based
    Others
    Segmentation by Deployment & Delivery:
    On-prem
    Cloud SaaS
    Edge / Embedded
    Hybrid
    Others

Segmentation by Application:

    Radiology & Imaging
    Cardiology
    Neurology
    Ophthalmology
    Oncology
    Primary Care
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Butterfly Network
    Merative
    Tempus
    RetinAi
    Nanox
    Lunit
    DiA Imaging
    Subtle Medical
    BrainMiner
    GE
    Siemens
    Aidoc
    Imagen Technologies, Inc.
    VUNO, Inc.
    Digital Diagnostics
    NeuraSignal
    Riverain Technologies, LLC
    Philips
    Microsoft
    Viz.ai
    RapidAI
    Canon Medical
    Enlitic
    BioMind
    ANNALISE-AI PTY LTD
    icometrix
    KONFOONG BIOTECH INTERNATIONAL CO., LTD?KFBIO?